AVITA Medical (AVHHL) Gains from Investment Securities (2019 - 2025)
AVITA Medical (AVHHL) reported Gains from Investment Securities of -$617000.0 for Q4 2025, down 240.23% on a YoY basis from $440000.0 in Q4 2024, and down 1126.08% quarter-over-quarter from $60132.0 in Q3 2025.
AVITA Medical (AVHHL) Gains from Investment Securities (2019 - 2025) Analysis & Trends
AVITA Medical has reported Gains from Investment Securities for 7 years, with the latest figure at -$617000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities fell 240.23% year-over-year to -$617000.0; the trailing twelve-month figure through Dec 2025 stood at -$555000.0 (down 214.67% YoY), and the FY2025 full-year result was $793137.0, down 77.6% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$617000.0, down from $60132.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $2.2 million in Q4 2022, with the low at -$680000.0 in Q2 2022.
- Historically, Gains from Investment Securities has averaged $395949.4 across 5 years, with a median of $132841.0 in 2024.
- Annual changes were most pronounced in 2021 — Gains from Investment Securities surged 52900.0% — and 2025, when it sank 384.55%.
- AVITA Medical's Gains from Investment Securities stood at $1.8 million in 2021, then climbed by 27.25% to $2.2 million in 2022, then plunged by 98.03% to $44000.0 in 2023, then surged by 900.0% to $440000.0 in 2024, then sank by 240.23% to -$617000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$617000.0 (Q4 2025), $60132.0 (Q3 2025), and -$378000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | AVITA Medical | - | - | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -617,000.00 |
| Dec 31, 2025 | -617,000.00 |
| Sep 30, 2025 | 60,132.00 |
| Sep 30, 2025 | 60,132.00 |
| Mar 31, 2025 | -378,000.00 |
| Mar 31, 2025 | -378,000.00 |
| Dec 31, 2024 | 440,000.00 |
| Dec 31, 2024 | 440,000.00 |
| Sep 30, 2024 | 239,369.00 |
| Sep 30, 2024 | 239,369.00 |
| Jun 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 132,841.00 |
| Mar 31, 2024 | 132,841.00 |
| Dec 31, 2023 | 44,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Sep 30, 2023 | 57,798.00 |
| Sep 30, 2023 | 57,798.00 |
| Dec 31, 2022 | 2.24 Mn |
| Dec 31, 2022 | 2.24 Mn |